Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
148581000001117 | Panadol Ultra 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare UK Ltd) | en | Synonym | Inactive | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
148591000001115 | Panadol Ultra 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare UK Ltd) (product) | en | Fully specified name | Inactive | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
2886091000001111 | Panadol Ultra 12.8mg/500mg tablets (Haleon UK Ltd) | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
2886101000001117 | Panadol Ultra 12.8mg/500mg tablets (Haleon UK Ltd) (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
17106101000001111 | Panadol Ultra 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare) (product) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
17106201000001116 | Panadol Ultra 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare) | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Panadol Ultra 12.8mg/500mg tablets (Haleon UK Ltd) 20 tablet | Is pack of | False | Panadol Ultra 12.8mg/500mg tablets (Haleon UK Ltd) | Inferred relationship | Existential restriction modifier | |
Panadol Ultra 12.8mg/500mg tablets (Haleon UK Ltd) 20 tablet | Has AMP | True | Panadol Ultra 12.8mg/500mg tablets (Haleon UK Ltd) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets